Editor's Note: The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma.

Authors	Daniel C Cho, Matthew B Cohen, David J Panka, Michael Collins, Musie Ghebremichael, Michael B Atkins, Sabina Signoretti, James W Mier
Journal	Clinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 25 Issue 13 Pg. 4194 (Jul 01 2019) ISSN: 1557-3265 [Electronic] United States
PMID	31263033 (Publication Type: Journal Article, Expression of Concern)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!